{"id":246314,"date":"2026-05-15T01:13:00","date_gmt":"2026-05-15T05:13:00","guid":{"rendered":"https:\/\/news-you-need.com\/index.php\/2026\/05\/15\/contracting-for-ai-in-clinical-trials-cybersecurity-monitoring-and-risk-allocation-part-3\/"},"modified":"2026-05-15T01:20:07","modified_gmt":"2026-05-15T05:20:07","slug":"contracting-for-ai-in-clinical-trials-cybersecurity-monitoring-and-risk-allocation-part-3","status":"publish","type":"post","link":"https:\/\/news-you-need.com\/index.php\/2026\/05\/15\/contracting-for-ai-in-clinical-trials-cybersecurity-monitoring-and-risk-allocation-part-3\/","title":{"rendered":"Contracting For AI In Clinical Trials Cybersecurity Monitoring And Risk Allocation (Part 3)"},"content":{"rendered":"<p><a href=\"https:\/\/www.clinicalleader.com\/doc\/contracting-for-ai-in-clinical-trials-cybersecurity-monitoring-and-risk-allocation-part-0001\">Contracting For AI In Clinical Trials Cybersecurity Monitoring And Risk Allocation (Part 3)<\/a><\/p>\n<p><a href=\"https:\/\/www.clinicalleader.com\/doc\/contracting-for-ai-in-clinical-trials-cybersecurity-monitoring-and-risk-allocation-part-0001\">https:\/\/www.clinicalleader.com\/doc\/contracting-for-ai-in-clinical-trials-cybersecurity-monitoring-and-risk-allocation-part-0001<\/a><\/p>\n<p>Publish Date: <a href=\"publish_date]\">2026-05-15 01:13:00<\/a><\/p>\n<p>Source Domain: <a href=\"www.clinicalleader.com\">www.clinicalleader.com<\/a><\/p>\n<p>By Katherine Leibowitz, Leibowitz Law<\/p>\n<p>This is the third installment of a three-part series on AI in clinical trial operations. Part 1\u00a0describes where AI appears in clinical trial operations and the questions organizations should be asking. Part 2 focuses on the contract provisions that address the resulting risks, particularly intellectual property, data rights, and regulatory compliance. Part 3 picks up with cybersecurity, monitoring and validation, and risk allocation. Each section lists key contract clauses to review.\u00a0 Even where not listed separately, indemnification and limitation of liability should be considered throughout.<\/p>\n<p>Many agreements now include AI-specific provisions. There is no standard form, and their content varies depending on how AI is used and the risks involved. The issues below span multiple contract provisions and should be considered in that context.<\/p>\n<p>For purposes of this series,\u00a0\u201cdata\u201d\u00a0refers broadly to data, documents, communications, and other information relating to the clinical trial, including outputs generated by AI systems using such information.<\/p>\n<h2>Cybersecurity<\/h2>\n<p><strong>Contract Clauses<\/strong>: Security, Indemnification, Limitation of Liability, and Insurance<\/p>\n<ul>\n<li><strong>Increased Vulnerability: <\/strong>AI platforms expand the attack surface for clinical trial data. Vulnerabilities in AI systems may also create indirect entry points into sponsor or site environments if security architecture and access controls are not properly implemented.<\/li>\n<li><strong>Data Leakage:<\/strong> AI systems may also introduce data leakage risks, particularly where platforms retain inputs, transmit data externally, or operate within multi-tenant environments. Similar risks arise when personnel enter trial materials into consumer AI tools outside of controlled systems.<\/li>\n<li><strong>Security Controls<\/strong>: Organizations should assess vendor security standards, certifications, audit rights, and incident response procedures, including breach notification obligations.<\/li>\n<\/ul>\n<h2>Monitoring And&#8230;<\/h2>\n<p><a href=\"https:\/\/www.clinicalleader.com\/doc\/contracting-for-ai-in-clinical-trials-cybersecurity-monitoring-and-risk-allocation-part-0001\">Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Contracting For AI In Clinical Trials Cybersecurity Monitoring And Risk Allocation (Part 3) https:\/\/www.clinicalleader.com\/doc\/contracting-for-ai-in-clinical-trials-cybersecurity-monitoring-and-risk-allocation-part-0001 Publish&#8230;<\/p>\n","protected":false},"author":1,"featured_media":246316,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/vertassets.blob.core.windows.net\/image\/092ee5b7\/092ee5b7-15d2-4a64-a391-ba4e60d4c0fc\/ai_contract_gettyimages_2207503201.png","fifu_image_alt":"","footnotes":""},"categories":[15],"tags":[20,30,57,27],"class_list":["post-246314","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cybersecurity","tag-artificial-intelligence","tag-breach","tag-security","tag-vulnerability"],"_links":{"self":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/246314"}],"collection":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/comments?post=246314"}],"version-history":[{"count":1,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/246314\/revisions"}],"predecessor-version":[{"id":246317,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/posts\/246314\/revisions\/246317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media\/246316"}],"wp:attachment":[{"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/media?parent=246314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/categories?post=246314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news-you-need.com\/index.php\/wp-json\/wp\/v2\/tags?post=246314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}